Sutton D G, McVey S, Gentle D, Hince A J, MacDonald N, McCallum S
1 Department of Medical Physics, Ninewells Hospital, NHS Tayside, Dundee, UK.
Br J Radiol. 2014 Sep;87(1041):20140157. doi: 10.1259/bjr.20140157. Epub 2014 Jun 27.
This article reports on a pilot study designed to collect dose data representative of current CT chest abdomen pelvis (CAP) practice in Scotland, make any immediately obvious interventions and to identify if the current UK diagnostic reference level (DRL) of 940 mGy cm is still appropriate. The aims are to identify if a Scotland-wide picture archiving and communication system (PACS)-based dose audit of a number of CT examinations is likely to have value in terms of optimization of patient doses and to comment on the significance of the results in terms of future optimization strategies.
Dose audit of CT CAP examinations at 32 different scanner sites across Scotland using accepted data collection and analysis methods. The minimum sample size was 30.
RESULTS indicate that CT CAP doses are lower than those previously reported (median, 800 mGy cm, 75th percentile 840 mGy cm) but follow a distribution that is not in keeping with the concept of DRLs as presently understood or implemented.
There is value in a PACS-based dose audit project to provide serial snapshots of patient doses as optimization efforts take place and to revise current knowledge about CT doses. In our opinion, the results call into question whether DRLs or the concept of "achievable dose" are suitable for devising optimization strategies once a certain degree of optimization has taken place.
The results reported here suggest that it may be time to take a different approach to optimization, concentrating on tools that are more refined than the DRL, which may have become more of a compliance tool than an aid to optimization.
本文报道了一项试点研究,旨在收集代表苏格兰当前胸部、腹部及盆腔CT(CAP)检查实际剂量的数据,进行任何即刻明显的干预措施,并确定英国目前940毫戈瑞·厘米的诊断参考水平(DRL)是否仍然适用。目的是确定基于苏格兰范围内图像存档与通信系统(PACS)的多项CT检查剂量审核在优化患者剂量方面是否可能具有价值,并就结果对未来优化策略的意义发表评论。
采用公认的数据收集和分析方法,对苏格兰32个不同扫描站点的CT CAP检查进行剂量审核。最小样本量为30。
结果表明,CT CAP剂量低于先前报道的剂量(中位数为800毫戈瑞·厘米,第75百分位数为840毫戈瑞·厘米),但其分布不符合目前所理解或实施的DRL概念。
基于PACS的剂量审核项目具有价值,可在进行优化工作时提供患者剂量的系列快照,并修正有关CT剂量的现有知识。我们认为,一旦进行了一定程度的优化,这些结果就会让人质疑DRL或“可实现剂量”的概念是否适合用于制定优化策略。
此处报道的结果表明,可能是时候采取不同的优化方法了,应专注于比DRL更精细的工具,因为DRL可能已更多地成为一种合规工具,而非优化辅助工具。